Literature DB >> 167567

Modification of involuntary movements by centrally acting drugs.

M Goldstein, A F Battista, T Miyamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 167567

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  4 in total

1.  Improving symptom control in early Parkinson's disease.

Authors:  Stuart H Isaacson; Robert A Hauser
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

2.  mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Authors:  Olga I Dadalko; Michael Siuta; Amanda Poe; Kevin Erreger; Heinrich J G Matthies; Kevin Niswender; Aurelio Galli
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

3.  Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.

Authors:  T A Caraceni; I Celano; E Parati; F Girotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154

4.  Oxpentifylline in Parkinson's disease.

Authors:  R B Godwin-Austen; J A Twomey; G Hanks; J Higgins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.